PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 160 of 612

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05926583: A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05344833: Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05049798: A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04658862: A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04644770: A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04444921: EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04357821: Combinatorial Therapy to Induce an HIV Remission

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04023552: Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03762733: Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03076554: A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02851706: Natural History of and Specimen Banking for People With Tumors of the Central Nervous System

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02194738: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02055209: Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01878045: Mechanisms of Diabetic Kidney Disease in American Indians

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01117870: Assess the Effectiveness of Pulse RadioFrequency in Patients With Chronic Lumbar Radicular Pain

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01087307: Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01081262: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00070564: S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00005927: Study of Adrenal Gland Tumors

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001208: Botulinum Toxin for the Treatment of Involuntary Movement Disorders

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001205: Natural History of Treated Neurocysticercosis and Long-Term Outcomes

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇯🇵Industryotsuka.comTier 1 · Company source

Otsuka Holdings Enters into Virtual PPA with Special Purpose Company Established with Sojitz –Advancing Carbon Neutral Initiatives through Expansion of Self-Generated Renewable Energy–

Otsuka Holdings RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk starts Korea phase 3 for dual-action obesity drug CagriSema - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Files World's First Approval Application for 4-1BB Bispecific Antibody Abandoned by Big Pharma

finance.biggo.comOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

The CMP Plot Thickens: Solicitor General Letter Casts FDA’s Tobacco Civil Money Penalty Scheme into Further Doubt

Hyman, Phelps & McNamara (FDA Law)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Prescient Therapeutics’ First-in-Class Cancer Drug Approaching a Pivotal Moment

smallcaps.com.auOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

As U.S.-China biotech race heats up, Seattle makes its case to D.C.

GeekWireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Prescient Therapeutics’ First-in-Class Cancer Drug Approaching a Pivotal Moment

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ganeshotsav 2026: CM Devendra Fadnavis Directs Mandals To Ensure Hygienic Prasad, Follow Food Safety Norms

Free Press JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Florida sues two pharmaceutical companies for fixing drug prices

WCTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Florida sues two pharmaceutical companies for fixing drug prices

WCTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer

Cure TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kane Biotech Announces Second Quarter 2026 Financial Results

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day

MarketWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fast-growing California biotech company CG Oncology relocates its HQ to Texas

Currently.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Senator Young Attends SK Hynix Groundbreaking Ceremony in West Lafayette

Senator Young (.gov)Original source
🌍Researchuab.eduTier 2 · Direct publisher

Small kids, big germs: Tips on keeping children in daycare healthy

University of Alabama at BirminghamOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

argenx (NASDAQ: ARGX) seals Forte deal for first-in-class autoimmune antibody

Stock TitanOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

Making Space for Jacob’s Big Dreams, Rooted in Family Support

BioMarin PharmaceuticalOriginal source
🌍Industrydarebioscience.comTier 1 · Company source

Press Release: Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series

Dare BioscienceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New pill provides a meaningful step forward for those fighting a rare and debilitating disease

MLive.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

President Trump Planning New Medicaid Drug-Pricing Deals | PharmExec

PharmExec.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recon: FDA weighs new deputy commissioner posts; Trump set to reveal more MFN drug pricing deals

RAPSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approval Opens New Chapter in Pancreatic Cancer Treatment

University of MiamiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves Brepocitinib for Dermatomyositis

Dermatology TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cassidy Faults Abortion Drug Makers on Online Oversight

NewsmaxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bausch + Lomb dry eye combo drop advances to phase 3 evaluation

Glance by Eyes On EyecareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How AI and RFID Boosts Supply Chain Visibility

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Constantia Flexibles Brings System-thinking Approach to Pharmaceutical Packaging Innovation at PACK EXPO International 2026

Healthcare PackagingOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cancer Biotech Kura Oncology Rallies to New High After CEO’s Stock Purchase

Barron'sOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Looking beyond natural sequences

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA puts experimental therapy that blocks HAE swelling on fast track

Angioedema NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biohaven advances key drug trials and secures $350M deal with SK Biopharmaceuticals

PluangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Federal court rejects PhRMA challenge to Medicare drug price negotiation

The HillOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharma Doesn't Have an AI Problem. It Has an Information Problem.

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biohaven: Buy Reiterated On Opakalim License Agreement For Epilepsy And More (NYSE:BHVN)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Press Release: Lauren Boebert Introduces Botanical Drug Development Act of 2026

Quiver QuantitativeOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

New data infrastructure award to help scientific communities build domain-specific platforms for collaborative data science and AI

University of California IrvineOriginal source